| Source: |
| Type: |
| Caspase-12: a member of the caspase family, a group of cysteine proteases that play a crucial role in programmed cell death, also known as apoptosis. Caspase-12 is specifically involved in the endoplasmic reticulum (ER) stress-induced apoptosis pathway. On one hand, caspase-12 can act as a tumor suppressor by promoting apoptosis in response to ER stress, which can occur in cancer cells due to their high metabolic rate and increased demand for protein synthesis. On the other hand, some studies have suggested that caspase-12 can also contribute to cancer progression and resistance to chemotherapy. For example, caspase-12 can be inactivated in certain types of cancer, such as breast and lung cancer, which can lead to reduced apoptosis and increased tumor growth. Role of Caspase-12: Function: Caspase-12 is involved in the apoptotic pathway triggered by ER stress. It can activate downstream effector caspases, leading to apoptosis. It also plays a role in the inflammatory response by processing pro-inflammatory cytokines. Location: Unlike many other caspases, caspase-12 is primarily localized in the cytosol and the ER. |
| Prostate Cancer: Alterations in genes such as ERG, SPOP, MYC, androgen receptor (AR), and CHD1, drive PCa progression. TP53 is the most commonly mutated gene in human cancer. HH↑, GLI-1↑, SHH↑ P53↓ The loss of p53 and/or other tumor suppressor genes, reduced capacity for DNA repair, the dysfunction of telomerase activity, and changes in the pathways that govern the growth of cells also mediate the progression of Pca. It has been well documented that Ca2+ influx and MDR1 upregulation are highly associated with GEM metabolism in human pancreatic carcinoma. Increased Growth factor IGF-1/IGF-1R axis activation mediated by both PI3K/Akt or RAF/MEK/ERK system and AR expression remains important in the development and progression of prostate cancer. It has been demonstrated that prostate cancer cells are relatively sensitive to heat stress. Long non-coding RNA MALAT1 has been reported as an oncogenic target in multiple types of cancers, including PC. |
| 132- | CUR, | Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:22 Cells:% prod#:% Target#:595 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid